Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain – results from a large observational study

By Hermanns Kai   Junker Uwe   Nolte Thomas  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 3, 2012-02 ,pp. : 299-311

Informa Healthcare

Access to resources Recommend Favorite

Naloxone as part of a prolonged release oxycodone/naloxone combination reduces oxycodone-induced slowing of gastrointestinal transit in healthy volunteers

By Smith Kevin   Hopp Michael   Mundin Gill   Bond Simon   Bailey Paul   Woodward Jo   Palaniappan Karuppan   Church Ann   Limb Marie   Connor Alyson  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 4, 2011-04 ,pp. : 427-439

Informa Healthcare

Access to resources Recommend Favorite

Oxycodone/Naloxone in the Management of Patients with Pain and Opioid–Induced Bowel Dysfunction

By  

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 124-135

Bentham Science Publishers

Access to resources Recommend Favorite

Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain

By Clemens Katri Elina   Mikus Gerd  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 2, 2010-02 ,pp. : 297-310

Informa Healthcare

Access to resources Recommend Favorite

Validated in vitro/in vivo correlation of prolonged-release oxycodone/naloxone with differing dissolution rates in relation to gastrointestinal transit times

By Mundin Gill E   Smith Kevin J   Mysicka Jana   Heun Gerhard   Krämer Mathias   Hahn Udo   Leuner Christian  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 12, 2012-12 ,pp. : 1495-1503

Informa Healthcare

Access to resources Recommend Favorite